Phase I Study of Ruxolitinib in Combination with Abemaciclib for Patients with Primary or Post-Polycythemia Vera/Essential Thrombocythemia Myelofibrosis by Bewersdorf, Jan Philipp, Verstovsek, Srdan, Derkach, Andriy, Masarova, Lucia, Pemmaraju, Naveen, Stein, Eytan, Mauro, Michael, Rampal, Raajit K, Bose, Prithviraj

Get full text

Prospective serum metabolomic profiling of lethal prostate cancer by Huang, Jiaqi, Mondul, Alison M., Weinstein, Stephanie J., Derkach, Andriy, Moore, Steven C., Sampson, Joshua N., Albanes, Demetrius

Get full text

Precision Lineage Deconvolution in Mixed Phenotype Acute Leukemia Using Cite-Seq Derived Hematopoietic Stages Identifies Lineage Dynamics Associated with Treatment Response by Dilip, Deepika, Galera, Pallavi, Nemirovsky, David, Lallo, Morgan, Menghrajani, Kamal, Derkach, Andriy, Levine, Ross L, Koche, Richard, Xiao, Wenbin, Glass, Jacob

Get full text

A Phase 1b Multi-Center Study of the FLT3 Inhibitor Gilteritinib in Combination with the IDH1 Inhibitor Ivosidenib or the IDH2 Inhibitor Enasidenib for Patients with Relapsed or Re... by Stein, Eytan M., Derkach, Andriy, Melamed, Gabrielle, Block, Alana, Kim, Janet, Georgieva, Gergana, Thompson, Vanessa, Levine, Ross L, Intlekofer, Andrew M., Abdel-Wahab, Omar, Tallman, Martin S.

Get full text

Subset testing and analysis of multiple phenotypes by Derkach, Andriy, Pfeiffer, Ruth M.

Get full text

High dimensional mediation analysis with latent variables by Derkach, Andriy, Pfeiffer, Ruth M., Chen, Ting‐Huei, Sampson, Joshua N.

Get full text

Group testing in mediation analysis by Derkach, Andriy, Moore, Steven C., Boca, Simina M., Sampson, Joshua N.

Get full text

Patients with AML and an IDH2-R172 Mutation Exhibit a Unique Response to Intensive Induction Chemotherapy, Suggesting Futility of Mid-Cycle Bone Marrow Biopsy and Caution When Cons... by Yisraeli Salman, Meira, Terry, Alexander R., Derkach, Andriy, Nemirovsky, David, Chin, Kuo-Kai, Valtis, Yannis K., Boussi, Leora, Spivey, Theresa, Xiao, Wenbin, Famulare, Christopher, Ciervo, Jenna, Rowe, Jacob M., Tallman, Martin S., Stein, Eytan M.

Get full text

HMA/Ven Treatment Modifications and Associated Outcomes in IDH-Mutant AML by Chin, Kuo-Kai, Derkach, Andriy, Famulare, Christopher, Gupta, Gaurav, Borge, Prabhakar, Geyer, Mark Blaine, Goldberg, Aaron D., Haque, Tamanna, Park, Jae H., Roeker, Lindsey, Tallman, Martin S., Stahl, Maximilian, Stein, Eytan M.

Get full text

Maintenance Therapy Cessation for Sustained MRD Negative Multiple Myeloma Patients by Korde, Neha, Diamond, Benjamin, Burge, Miranda, Hassoun, Hani, Landau, Heather, Hultcrantz, Malin, Mailankody, Sham, Maclachlan, Kylee H, Shah, Urvi A, Derkach, Andriy, Usmani, Saad, Landgren, Ola, Lesokhin, Alexander

Get full text

Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities by Oben, Bénedith, Froyen, Guy, Maclachlan, Kylee H., Leongamornlert, Daniel, Abascal, Federico, Zheng-Lin, Binbin, Yellapantula, Venkata, Derkach, Andriy, Geerdens, Ellen, Diamond, Benjamin T., Arijs, Ingrid, Maes, Brigitte, Vanhees, Kimberly, Hultcrantz, Malin, Manasanch, Elisabet E., Kazandjian, Dickran, Lesokhin, Alexander, Dogan, Ahmet, Zhang, Yanming, Mikulasova, Aneta, Walker, Brian, Morgan, Gareth, Campbell, Peter J., Landgren, Ola, Rummens, Jean-Luc, Bolli, Niccolò, Maura, Francesco

Get full text

Pre-diagnosis dietary patterns and risk of multiple myeloma in the NIH-AARP diet and health study by Castro, Francesca, Parikh, Richa, Eustaquio, Jelyn C., Derkach, Andriy, Joseph, Janine M., Lesokhin, Alexander M., Usmani, Saad Z., Shah, Urvi A.

Get full text

Despite High Rates of Remission, Treatment of IDH-Mutant AML with Hypomethylating Agents and Venetoclax Is Associated with Frequent Treatment Delays, Modifications, and Transfusion... by Chin, Kuo-Kai, Derkach, Andriy, Famulare, Christopher, Gupta, Gaurav, Borge, Prabhakar, Berman, Ellin, Geyer, Mark Blaine, Goldberg, Aaron D., Haque, Tamanna, Rampal, Raajit K., Park, Jae H., Roeker, Lindsey E., Tallman, Martin S., Stein, Eytan M.

Get full text

Impact of Symptom Benefit and Transfusion Response on Survival in Myelofibrosis Patients Treated with Pacritinib: PERSIST-2 Landmark Survival Analysis by Ajufo, Helen, Bewersdorf, Jan Philipp, Harrison, Claire N, Palandri, Francesca, Mascarenhas, John, Palmer, Jeanne, Gerds, Aaron T., Kiladjian, Jean-Jacques, Buckley, Sarah, Derkach, Andriy, Roman-Torres, Karisse, Rampal, Raajit K.

Get full text

Dietary Patterns Among Individuals with Plasma Cell Disorders Compared to the General US Population by Traore, Kadiatou, Taneja, Alankrita, Gorshein, Elan, Castro, Francesca, Derkach, Andriy, Hurtado Martinez, Jorge Arturo, Serrano, Edith, Lesokhin, Alexander, Ahlstrom, Jennifer M., Block, Torin, Hydren, Jay R., Usmani, Saad Z, Shah, Urvi A

Get full text

Abstract 5051: Associations between autoimmune conditions and gastric cancer risk among elderly US adults by Song, Minkyo, Camargo, M. Constanza, Derkach, Andriy, Engels, Eric A., Rabkin, Charles S.

Get full text

E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: a phase II clinical trial by Bewersdorf, Jan Philipp, Stahl, Maximilian, Taylor, Justin, Mi, Xiaoli, Chandhok, Namrata Sonia, Watts, Justin, Derkach, Andriy, Wysocki, Mateusz, Lu, Sydney X., Bourcier, Jessie, Hogg, Simon J., Rahman, Jahan, Chaudhry, Sana, Totiger, Tulasigeri M., Abdel-Wahab, Omar, Stein, Eytan M.

Get full text

Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML by Stahl, Maximilian, Menghrajani, Kamal, Derkach, Andriy, Chan, Alexander, Xiao, Wenbin, Glass, Jacob, King, Amber C., Daniyan, Anthony F., Famulare, Christopher, Cuello, Bernadette M., Horvat, Troy Z., Abdel-Wahab, Omar, Levine, Ross L., Viny, Aaron D., Stein, Eytan M., Cai, Sheng F., Roshal, Mikhail, Tallman, Martin S., Goldberg, Aaron D.

Get full text

Multilineage involvement in KMT2A‐rearranged B acute lymphoblastic leukaemia: cell‐of‐origin, biology, and clinical implications by Aypar, Umut, Dilip, Deepika, Gadde, Ramya, Londono, Dory M, Liu, Ying, Gao, Qi, Geyer, Mark B, Derkach, Andriy, Zhang, Yanming, Glass, Jacob L, Roshal, Mikhail, Xiao, Wenbin

Get full text

BMP2/SMAD pathway activation in JAK2/p53-mutant megakaryocyte/erythroid progenitors promotes leukemic transformation by Li, Bing, An, Wenbin, Wang, Hua, Baslan, Timour, Mowla, Shoron, Krishnan, Aishwarya, Xiao, Wenbin, Koche, Richard P, Liu, Ying, Cai, Sheng F, Xiao, Zhijian, Derkach, Andriy, Iacobucci, Ilaria, Mullighan, Charles G, Helin, Kristian, Lowe, Scott W, Levine, Ross L, Rampal, Raajit K

Get full text